EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
- Resource Type
- journal article
- Source
- Medical Oncology; Oct2017, Vol. 34 Issue 10, p1-11, 11p
- Subject
- Language
- ISSN
- 13570560